Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ADAP will rise by +11.85% over the next 2 Weeks and hit $0.11 by Wednesday, August 13, 2025. In that time frame, ADAP's share price is expected to range between $0.07 and $0.15.
BearishAverageBullishADAP shares fell -5.05% in Wednesday, July 30, 2025's trading session, dropping from a previous close of $0.10 to move at $0.10. The stock demonstrated notable intraday movement (see ADAP's key stats for a full breakdown), fluctuating between $0.10 and $0.11, a +15.36% trading range. While recent weeks have seen some volatility, ADAP has managed to secure a -63.98% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 40.33M shares changing hands, 8.59M fewer than the previous session. This amounted to $4.02M in total market activity.
Will ADAP Continue Its Upward Trend?
According to analyst ratings and projections for ADAP, Adaptimmune Therapeutics plc shares are anticipated to increase by +34.28%, potentially reaching $0.15 per share by August 13, 2025. Short-term technical indicators currently suggest a neutral sentiment for ADAP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the ADAP stock forecast, now is a good time to buy ADAP stock because its current trading price is -10.59% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ADAP covering social and institutional perspectives.
ADAP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ADAP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 23.71% to 30.21%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 36.30%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.57%, maintains a neutral outlook for the long term. Insights into ADAP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Adaptimmune Therapeutics Short-Term Forecasts
ADAP Forecast For Next 5 Days
Our algorithm anticipates Adaptimmune Therapeutics (ADAP) stock could hit $0.12 by Aug 07, 2025. This represents a +23.39% fall from today's price, following a -65.66% change over the past five days.
ADAP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Adaptimmune Therapeutics plc (ADAP) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.11, which would mean a +10.44% increase from the current price of $0.10. Projections for this period range from a high of $0.17 to a low of $0.03.
ADAP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Adaptimmune Therapeutics's price over the next three months point to a rise. ADAP stock is expected to peak at $0.93 on Jul 31, 2025 before potentially dipping to $0.10 on Sep 16, 2025. On average, ADAP is likely to trade around $0.45 in the coming 90 days.
Adaptimmune Therapeutics Stock Forecast 2025
Based on our predictive models, Adaptimmune Therapeutics (ADAP) is expected to trade between $0.07 and $0.93 throughout 2025. This would result in an average price of $0.38, potentially offering investors a +281.53% return from current levels.
Adaptimmune Therapeutics plc Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Adaptimmune Therapeutics plc (ADAP) is positioned to show a strong performance in July 2025. The price is predicted to move between $0.87 and $0.93, settling at an average of $0.90. This could translate to a +803.61% gain.
August 2025
Based on current market signals, Adaptimmune Therapeutics plc is projected to trend august 2025. We forecast a trading range from $0.44 to $0.93, with a likely average price of $0.67. Investors could expect a potential return of +572.69%.
September 2025
Our predictive algorithms indicate Adaptimmune Therapeutics plc stock may see a shift in September 2025. The expected range spans $0.10–$0.49, with an average target of $0.26. This represents a positive outlook and a possible gain of +161.04%.
October 2025
Analyzing established trends, Adaptimmune Therapeutics plc looks set to move in October 2025. Projections place the stock between $0.32 and $0.51, averaging around $0.42. This suggests a +321.69% gain from current levels.
November 2025
Market indicators suggest Adaptimmune Therapeutics plc could experience notable changes during November 2025. Prices could fluctuate within $0.26 to $0.55, with a midpoint forecast of $0.40. The stock might deliver a +301.61% gain.
December 2025
Forecasting for December 2025, models estimate that Adaptimmune Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.07 and $0.28, averaging $0.17. This signals a positive trajectory with potential returns around +70.68%.
January 2026
According to our latest forecast models, Adaptimmune Therapeutics plc (ADAP) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.05 and $0.24, settling at an average of $0.18. This could translate to a +80.72% gain.
February 2026
Based on current market signals, Adaptimmune Therapeutics plc is projected to trend february 2026. We forecast a trading range from $0.03 to $0.24, with a likely average price of $0.18. Investors could expect a potential return of +80.72%.
March 2026
Our predictive algorithms indicate Adaptimmune Therapeutics plc stock may see a shift in March 2026. The expected range spans $0.00–$0.24, with an average target of $0.23. This represents a positive outlook and a possible gain of +130.92%.
April 2026
Analyzing established trends, Adaptimmune Therapeutics plc looks set to move in April 2026. Projections place the stock between $0.00 and $0.09, averaging around $0.09. This suggests a -9.64% loss from current levels.
May 2026
Market indicators suggest Adaptimmune Therapeutics plc could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $0.03, with a midpoint forecast of $0.11. The stock might deliver a +10.44% gain.
June 2026
Forecasting for June 2026, models estimate that Adaptimmune Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.03, averaging $0.05. This signals a cautious trajectory with potential returns around -49.80%.
July 2026
According to our latest forecast models, Adaptimmune Therapeutics plc (ADAP) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $0.02, settling at an average of $0.05. This could translate to a -49.80% loss.
ADAP's history of dividends and stock splits also plays a role in long-term investor confidence.